Delivery Order SPE2DB22D3301-SPE2DB24FY5SF
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,336.60 firm fixed-price delivery order is for the procurement of DEXMEDETOMIDINE 200 MCG/2 ML 2ML, a medical product, with a completion date of December 15, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- The U.S. federal government awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of the drug Dexmedetomidine 400mcg/100ml-NS 100ml. The $2,167.80 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which manages logistics and acquisition for the Department of Defense (DoD). This contract is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the pharmaceutical product Dexmedetomidine 200 mcg/2 ml 2 ml. The contract has a ceiling value of $1,708.81 and a period of performance through March 19, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of DEXMEDETOMIDIN 400MCG/100ML-NS 100ML, a pharmaceutical product, with a ceiling value of $3,018.78. The contract is a firm fixed-price delivery order with a performance period ending on June 30, 2025. This award is not set aside and represents an open competition contract. AmerisourceBergen Drug Corp is...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568233987 - Dexmedetomidine 200 mcg/2 ml 2 ml, a medication used for sedation. The contract has a firm fixed price of $1,244.00 and a completion date of May 14, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4,564,203,919 units of the pharmaceutical product Dexmedetomidine 200 mcg/2 ml 2 ml. The order has a ceiling value of $4,104.39 and a period of performance through April 9, 2024. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order, valued at $2,705.43, is for the supply of the pharmaceutical product Dexmedetomidine 400mcg/100ml-NS 100ml. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a period of...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of dexmedetomidine 200 mcg/2 ml vials. The award, valued at $3,889.83, has a firm-fixed-price contract type and an ultimate completion date of August 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of DEXMEDETOMIDINE 200 MCG/2 ML 2ML pharmaceuticals, with a potential value of $1,551.10. The award has a completion date of January 16, 2024 and was made on a firm fixed price basis. No set-aside designation was used for this contract. Amerisourcebergen Drug Corp has a history of providing...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,648.87 firm fixed-price delivery order is for the supply of DEXMEDETOMIDINE 200MCG/50ML-NS 50ML, a medical product used for various healthcare applications. The contract has an ultimate completion date of January 3, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY5SFDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the provision of 4564435979 - DEXMEDETOMIDINE 200 MCG/2 ML 2ML. The contract, valued at $2,539.91, has a period of performance through April 30, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This delivery order contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 4/29/24 |